128 related articles for article (PubMed ID: 10202583)
1. Normal CSF oxytocin and NPY levels in OCD.
Altemus M; Jacobson KR; Debellis M; Kling M; Pigott T; Murphy DL; Gold PW
Biol Psychiatry; 1999 Apr; 45(7):931-3. PubMed ID: 10202583
[TBL] [Abstract][Full Text] [Related]
2. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
Leckman JF; Goodman WK; North WG; Chappell PB; Price LH; Pauls DL; Anderson GM; Riddle MA; McSwiggan-Hardin M; McDougle CJ
Arch Gen Psychiatry; 1994 Oct; 51(10):782-92. PubMed ID: 7524462
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report.
Martin A; State M; Anderson GM; Kaye WM; Hanchett JM; McConaha CW; North WG; Leckman JF
Biol Psychiatry; 1998 Dec; 44(12):1349-52. PubMed ID: 9861478
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder.
Cappi C; Diniz JB; Requena GL; Lourenço T; Lisboa BC; Batistuzzo MC; Marques AH; Hoexter MQ; Pereira CA; Miguel EC; Brentani H
BMC Neurosci; 2016 Nov; 17(1):79. PubMed ID: 27903255
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin receptor gene polymorphisms exert a modulating effect on the onset age in patients with obsessive-compulsive disorder.
Kang JI; Kim HW; Kim CH; Hwang EH; Kim SJ
Psychoneuroendocrinology; 2017 Dec; 86():45-52. PubMed ID: 28915380
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls.
Leckman JF; Goodman WK; Anderson GM; Riddle MA; Chappell PB; McSwiggan-Hardin MT; McDougle CJ; Scahill LD; Ort SI; Pauls DL
Neuropsychopharmacology; 1995 Feb; 12(1):73-86. PubMed ID: 7766289
[TBL] [Abstract][Full Text] [Related]
7. Age-related increase in neuropeptide Y-like immunoreactivity in cerebrospinal fluid in women.
Taniguchi S; Yanase T; Kurimoto F; Takayanagi R; Haji M; Kurose S; Nawata H
Fukuoka Igaku Zasshi; 1994 Dec; 85(12):361-5. PubMed ID: 7883275
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.
Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507
[TBL] [Abstract][Full Text] [Related]
9. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder.
Sah R; Ekhator NN; Strawn JR; Sallee FR; Baker DG; Horn PS; Geracioti TD
Biol Psychiatry; 2009 Oct; 66(7):705-7. PubMed ID: 19576571
[TBL] [Abstract][Full Text] [Related]
10. Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder.
Park CI; Kim HW; Jeon S; Kang JI; Kim SJ
Clin Epigenetics; 2020 Jul; 12(1):101. PubMed ID: 32631409
[TBL] [Abstract][Full Text] [Related]
11. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
Altemus M; Swedo SE; Leonard HL; Richter D; Rubinow DR; Potter WZ; Rapoport JL
Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
[TBL] [Abstract][Full Text] [Related]
12. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic dysfunction in OCD.
Chakrabarty K; Bhattacharyya S; Christopher R; Khanna S
Neuropsychopharmacology; 2005 Sep; 30(9):1735-40. PubMed ID: 15841109
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Schebesch KM; Brawanski A; Bele S; Schödel P; Herbst A; Bründl E; Kagerbauer SM; Martin J; Lohmeier A; Stoerr EM; Proescholdt M
Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659
[TBL] [Abstract][Full Text] [Related]
15. Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.
Schebesch KM; Bründl E; Schödel P; Hochreiter A; Scheitzach J; Bele S; Brawanski A; Störr EM; Lohmeier A; Proescholdt M
J Neurosurg Anesthesiol; 2017 Jul; 29(3):312-316. PubMed ID: 27438796
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects.
Coccaro EF; Lee R; Liu T; Mathé AA
Biol Psychiatry; 2012 Dec; 72(12):997-1003. PubMed ID: 22985695
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders.
von Holst H; Rudehill A; Lundberg JM
Acta Neurochir (Wien); 1991; 112(3-4):132-5. PubMed ID: 1776515
[TBL] [Abstract][Full Text] [Related]
18. Plasma Oxytocin Levels in Untreated Adult Obsessive-Compulsive Disorder Patients.
Marazziti D; Baroni S; Giannaccini G; Catena-Dell'Osso M; Piccinni A; Massimetti G; Dell'Osso L
Neuropsychobiology; 2015; 72(2):74-80. PubMed ID: 26509891
[TBL] [Abstract][Full Text] [Related]
19. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe.
Baker DG; Bertram TM; Patel PM; Barkauskas DA; Clopton P; Patel S; Geracioti TD; Haji U; O'Connor DT; Nievergelt CM; Hauger RL
Psychoneuroendocrinology; 2013 Oct; 38(10):2378-82. PubMed ID: 23759334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
